Genfit S.A./€GNFT

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Genfit S.A.

Genfit S.A. is a French biopharmaceutical company focused on developing therapeutics and diagnostic solutions for metabolic and liver-related diseases. Known for its work in treating nonalcoholic steatohepatitis (NASH) and other liver diseases, Genfit offers key products including investigational drugs such as elafibranor and diagnostic tests like NIS4 for identifying NASH. Founded in 1999, the company is headquartered in Loos, France. Its strategic positioning lies in addressing unmet medical needs in liver health, supported by a robust research and development pipeline. Genfit's competitive strengths include expertise in nuclear receptor pathways and strategic partnerships with other biopharmaceutical firms.

Ticker

€GNFT

Primary listing

PAR

Industry

Biotechnology
Headquarters

Employees

180

Genfit S.A. Metrics

BasicAdvanced
€173M
115.80
€0.03
1.07
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €GNFT

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs